Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Trial Evaluating the Safety and Efficacy of Tumor Thermosensitive Embolic Agent in Transcatheter Arterial Chemoembolization for Primary Liver Cancer

NCT07356531 is registered in ClinicalTrials.gov with JIANGSU SHENMING Medical Technology CO., Ltd as lead sponsor.

NCT NCT07356531
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07356531 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Trial Evaluating the Safety and Efficacy of Tumor Thermosensitive Embolic Agent in Transcatheter Arterial Chemoembolization for Primary Liver Cancer
Lead sponsor
JIANGSU SHENMING Medical Technology CO., Ltd
Phase
Not applicable
Overall status
Recruiting
Start date
July 29, 2024
Completion date
May 31, 2026
Enrollment
216 (estimated)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

liver cancer